Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Funapide in Postherpetic Neuralgia
NCT02365636Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of funapide in postherpetic neuralgia (PHN), sponsored by Teva Pharmaceutical Industries Ltd.. Started Feb 2015; status: completed.
02
Drugs
funapide
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT02365636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365636.